1 |
Larkins N, Kim S, Craig J, et al. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children [J]. Archives of Disease in Childhood, 2016, 101(4): 404-408.
|
2 |
Tiwari S, Seth A. Nephrotic Syndrome in Children - A Tale of 50 Years [J]. Indian Pediatrics, 2016, 53(12): 1097-1098.
|
3 |
中华医学会儿科学分会肾脏病学组. 激素耐药型肾病综合征诊治循证指南(2016) [J]. 中华儿科杂志, 2017, 55(11): 805-809.
|
4 |
中华医学会儿科学分会肾脏病学组. 儿童激素敏感、复发/依赖肾病综综合征诊治循证指南(2016) [J]. 中华儿科杂志, 2017, 55(10): 729-734.
|
5 |
中华医学会儿科学分会肾脏病学组. 儿童常见肾脏疾病诊治循证指南(一):激素敏感、复发/依赖肾病综合征诊治循证指南(试行) [J]. 中华儿科杂志, 2009, 47(3): 167-170.
|
6 |
中华医学会儿科学分会肾脏病学组. 儿童常见肾脏疾病诊治循证指南(试行)(三):激素耐药型肾病综合征诊治指南 [J]. 中华儿科杂志, 2010, 48(1): 76-78.
|
7 |
张宏文,张琰琴,刘晓宇,等. Dent病6例临床诊治分析 [J]. 临床儿科杂志, 2016, 34(6): 418-420.
|
8 |
He G, Zhang H, Wang F, et al. Diagnosis and treatment of Dent disease in 10 Chinese boys [J]. Intractable & Rare Diseases Research, 2017, 6(1): 41-45.
|
9 |
何国华,张宏文,王芳,等. 儿童Dent病4例的肾脏病理改变分析 [J]. 中华实用儿科临床杂志, 2017, 32(5): 387-389.
|
10 |
Lombel RM, Hodson EM, Gipson DS, et al. Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO [J]. Pediatric Nephrology (Berlin, Germany), 2013, 28(3): 409-414.
|
11 |
张宏文. 关于儿童肾脏疾病的某些思索 [J]. 临床儿科杂志, 2018, 36(6): 401-404.
|
12 |
Hoyer PF, Brodeh J. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial [J]. J Am Soc Nephrol, 2006, 17(4): 1151-1157.
|
13 |
Kaku Y, Ohtsuka Y, Komatsu Y, et al. Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy [J]. Clinical and Experimental Nephrology, 2015, 19(1): 34-53.
|
14 |
张宏文,姚勇,苏白鸽,等. 初诊为原发性肾炎型肾病综合征患儿的病因构成分析——对国内儿童原发性肾病综合征临床分型的商榷 [J]. 中国循证儿科杂志, 2018, 13(3): 364-366.
|
15 |
Ahmed HM. Tacrolimus can induce remission in cyclosporine and mycophenolate mofetil resistant pediatric onset nephrotic syndrome [J]. Iranian Journal of Kidney Diseases, 2019, 13(5): 322-327.
|
16 |
谢冰,孙会静,熊礼佳. 吗替麦考酚酯联合他克莫司治疗难治性肾病综合征临床研究 [J]. 中国药业, 2019, 28(7): 50-53.
|
17 |
邓薇,王利民,黄远莲,等. 霉酚酸酯联合他克莫司治疗激素抵抗型难治性肾病综合征分析 [J]. 世界临床医学, 2019, 13(1): 64-65.
|
18 |
Mao Y, Yin L, Huang H, et al. Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy [J]. The Journal of International Medical Research, 2019, 47(1): 105-113.
|
19 |
Jesus D, Rodrigues M, da Silva JAP, et al. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis [J]. Lupus, 2018, 27(8): 1358-1362.
|
20 |
Park DJ, Kang JH, Lee KE, et al. Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study [J]. Clinical and Experimental Rheumatology, 2019, 37(1): 89-96.
|
21 |
Nikolopoulou A, Condon M, Turner-Stokes T, et al. Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial [J]. BMC Nephrology, 2019, 20(1): 352.
|
22 |
Almutairi A, Alkathiri Z, Al-Mayouf SM. Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis [J]. International Journal of Pediatrics & Adolescent Medicine, 2018, 5(3): 99-102.
|
23 |
Kamei K, Ishikura K. Rituximab treatment for refractory steroid-resistant nephrotic syndrome [J]. Pediatric Nephrology (Berlin, Germany), 2016, 31(2): 337-338.
|